A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice

Parasitology

Volumn 134, Issue 10, 2007, Pages 1339-1346

  Zhang, G ^a   Huong, V T T ^a   Battur, B ^a   Zhou, J ^a   Zhang, H ^a   Liao, M ^a   Kawase, O ^a   Lee, E G ^a   Dautu, G ^a   Igarashi, M ^a   Nishikawa, Y ^a   Xuan, X ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

Author keywords

DNA vaccine; GRA4; Toxoplasma gondii; Vaccinia virus

Indexed keywords

DENSE GRANULE ANTIGEN 4; DNA VACCINE; GAMMA INTERFERON; RECOMBINANT ANTIGEN; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HETEROLOGOUS EXPRESSION; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT PLASMID; TOXOPLASMA GONDII; TOXOPLASMOSIS; VACCINIA VIRUS;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY FORMATION; BRAIN; CERCOPITHECUS AETHIOPS; FEMALE; IMMUNITY, CELLULAR; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; TIME FACTORS; TOXOPLASMA; TOXOPLASMOSIS; VACCINES, DNA; VACCINIA VIRUS; VERO CELLS;

MUS; TOXOPLASMA GONDII; VACCINIA VIRUS;

EID: 34547743847     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182007002892     Document Type: Article

References (25)

1. Boldbaataar, D., Xuan, X., Kimbita, N., Huang, X., Igarashi, I., Byambaa, B., Battsetseg, B., Battur, B., Battsetseg, G., Batsukh, Z., Nagasawa, H., Fujisaki, K. and Mikami, T. (2001). Detection of antibodies to Hypoderma lineatum in cattle by Western blotting with recombinant hypodermin C antigen. Veterinary Parasitology 99, 147-154.
2. Buxton, D. (1993). Toxoplasmosis: the first commercial vaccine. Parasitology Today 9, 335-337.
3. Chardes, T., Bourguin, I., Mevelec, M. N., Dubremetz, J. F. and Bout, D. (1990). Antibody responses to Toxoplasma gondii in sera, intestinal secretions and milk from orally infected mice and characterization of target antigens. Infection and Immunity 58, 1240-1246.
4. Desolme, B., Mevelec, M. N., Buzoni, G. D. and Bout, D. (2000). Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine 18, 2512-2521.
5. Dubey, J. P. (2004). Toxoplasmosis - a waterborne zoonosis. Veterinary Parasitology 126, 57-72.
6. Haumont, M., Delhaye, L., Garcia, L., Jurado, M., Mazzu, P., Daminet, V., Verlant, V., Bollen, A., Biemans, R. and Jacquet, A. (2000). Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a guinea pig model. Infection and Immunity 68, 4948-4953.
7. Indresh, K. S., Margaret, A. and Liu, M. D. (2003). Gene vaccines. Annals of Internal Medicine 138, 550-559.
8. Irvine, K. R., Chamberlain, R. S., Shulman, E. P., Surman, D. R., Rosenberg, S. A. and Restifo, N. P. (1997). Enhancing efficacy of recombinant anticancer vaccines with prime/boost regimens that use two different vectors. Journal of the National Cancer Institute 89, 1595-1601.
9. Kim, K. and Weiss, L. M. (2004). Toxoplasma gondii: the model apicomplexan. International Journal for Parasitology 34, 423-432.
10. Kobayashi, M., Aosai, F., Hata, H., Mun, H. S., Tagawa, Y., Iwakura, Y. and Yano, A. (1999). Toxoplasma gondii: differences of invasion into tissue of digestive organs between susceptible and resistant strain and influence of IFN-γ in mice inoculated with the cyst perorally. The Journal of Parasitology 85, 973-975.
11. Kristina, K. P., Rao, M. and Alving, C. R. (2003). Immunization with DNA through the skin. Methods 31, 232-242.
12. Martin, V., Supanitsky, A., Echeverria, P. C., Litwin, S., Tanos, T., Roodt, A. R., Guarnera, E. A. and Angel, S. O. (2004). Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis. Clinical and Diagnostic Laboratory Immunology 11, 704-710.
13. Mevelec, M. M., Bout, D., Desolme, B., Marchand, H., Magne, R., Bruneel, O. and Buzoni, G. D. (2005). Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Vaccine 23, 4489-4499.
14. Miao, J., Li, X., Liu, Z., Xue, C., Bujard, H. and Cui, L. (2006). Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines. Vaccine 24, 6187-6198.
15. Moore, A. C. and Hill, A. V. (2004). Progress in DNA-based heterologous prime-boost immunization strategies for malaria. Immunological Reviews 199, 126-143.
16. Nishikawa, Y., Iwata, A., Katsumata, A., Xuan, X., Nagasawa, H., Igarashi, I., Fujisaki, K., Otsuka, H. and Mikami, T. (2001). Expression of canine interferon-gamma by a recombinant vaccinia virus and its antiviral effect. Virus Research 75, 113-121.
17. Ogra, P. L., Faden, H. S., Abraham, R., Duffy, L. C., Sun, M. and Minor, P. D. (1991). Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines. The Journal of Infectious Diseases 164, 191-194.
18. Ramshaw, I. A. and Ramsay, A. J. (2000). The prime-boost strategy: exciting prospects for improved vaccination. Immunology Today 21, 163-165.
19. Rorman, E., Zamir, C. S., Rilkis, I. and Ben, D. H. (2006). Congenital toxoplasmosis-prenatal aspects of Toxoplasma gondii infection. Reproductive Toxicology 21, 458-472.
20. Saito, S., Aosai, F., Rikihisa, F., Mun, H. S., Norose, K., Chen, M., Kuroki, T., Asano, T., Ochiai, T., Hata, H., Ichinose, M. and Yano, A. (2001). Establishment of gene-vaccinated skin grafting against Toxoplasma gondii infection in mice. Vaccine 19, 2172-2180.
21. Shedlock, D. J. and Weiner, D. B. (2000). DNA vaccination: antigen presentation and the induction of immunity. Journal of Leukocyte Biology 68, 793-806.
22. Vuola, J. M., Keating, S., Webster, D. P., Berthoud, T., Dunachie, S., Gilbert, S. C. and Hill, A. V. (2005). Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers. The Journal of Immunology 174, 449-455.
23. Weiss, R., Scheiblhofer, S., Freund, J., Ferreira, F., Livey, I. and Thalhamer, J. (2002). Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th-inducing effect of immunostimulatory CpG motifs in DNA vaccines. Vaccine 20, 3148-3154.
24. Xuan, X., Nakamura, T., Sato, I., Tuchiya, K., Nosetto, E., Ishihana, A. and Ueda, S. (1995). Characterization of pseudorabies virus glycoprotein gII expressed by recombinant baculovirus. Virus Research 36, 151-161.
25. Yap, J. S. and Sher, A. (1999). Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology 201, 240-247.